That said, expectations should be clear
Retatrutide study-design context Retatrutide has been studied in once-weekly clinical-study settings and is discussed as an investigational triple receptor agonist
Theres also no consensus on exactly how much medication is in a so-called microdose
But dont erase the entire category
Therefore, in the present study, using a segmental osteoperiosteal bone defect (0.8 cm, in the middle of the left radius) that remained incompletely healed in all control rabbits for 6 weeks (assessed in 2-week intervals), pentadecapeptide BPC-157 was further studied (either percutaneously given locally [10 g/kg body weight] into the bone defect, or applied intramuscularly [intermittently, at postoperative days 7, 9, 14, and 16 at 10 g/kg body weight] or continuously [once per day, postoperative days 721 at 10 g or 10 ng/kg body weight])
While I'm a huge fan of the Strawberry Banana Gladiator, I know many of you are curious about other options